An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.
Saved in:
| Title: | An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV. |
|---|---|
| Authors: | Guo H; IGM Biosciences, Mountain View, CA, USA., Cho B; IGM Biosciences, Mountain View, CA, USA., Hinton PR; IGM Biosciences, Mountain View, CA, USA., He S; IGM Biosciences, Mountain View, CA, USA., Yu Y; IGM Biosciences, Mountain View, CA, USA., Ramesh AK; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Sivaccumar JP; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Campo K; IGM Biosciences, Mountain View, CA, USA., Holland S; IGM Biosciences, Mountain View, CA, USA., Sachdeva S; IGM Biosciences, Mountain View, CA, USA., Mensch C; IGM Biosciences, Mountain View, CA, USA., Dawod M; IGM Biosciences, Mountain View, CA, USA., Whitaker A; Cellular, Molecular, and Biomedical Sciences Graduate Program, University of Vermont, Burlington, VT, USA.; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Eisenhauer P; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Falcone A; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Honce R; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT, USA., Botten JW; Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, University of Vermont, Burlington, VT, USA.; Department of Microbiology and Molecular Genetics, Robert Larner, M.D. College of Medicine, University of Vermont, Burlington, VT, USA., Carroll SF; IGM Biosciences, Mountain View, CA, USA., Keyt BA; IGM Biosciences, Mountain View, CA, USA., Womack AW; IGM Biosciences, Mountain View, CA, USA., Strohl WR; IGM Biosciences, Mountain View, CA, USA., Xu K; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ha S; IGM Biosciences, Mountain View, CA, USA., Shiver JW; IGM Biosciences, Mountain View, CA, USA., Fu TM; IGM Biosciences, Mountain View, CA, USA. |
| Source: | Emerging microbes & infections [Emerg Microbes Infect] 2023 Dec; Vol. 12 (2), pp. 2275598. Date of Electronic Publication: 2023 Dec 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2222-1751 |
|---|---|
| DOI: | 10.1080/22221751.2023.2275598 |
